Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform

Abstract Access to a comprehensive molecular alteration screening is patchy in Europe and quality of the molecular analysis varies. SPECTAlung was created in 2015 as a pan-European screening platform for patients with thoracic malignancies. Here we report the results of almost 4 years of prospective...

Full description

Bibliographic Details
Main Authors: M. Morfouace, S. Novello, A. Stevovic, C. Dooms, U. Janžič, T. Berghmans, R. Dziadziuszko, T. Gorlia, E. Felip, L. Paz-Ares, J. Mazieres, M. O’Brien, P. Bironzo, J. Vansteenkiste, L. Lacroix, A. C. Dingemans, V. Golfinopoulos, B. Besse
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-12056-0

Internet

https://doi.org/10.1038/s41598-022-12056-0

Similar Items